Open AccessAssociation between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis
Author(s) -
Peter J. Godolphin,
David J. Fisher,
Lindsay R. Berry,
Lennie Derde,
Janet Dı́az,
Anthony Gordon,
Elizabeth Lorenzi,
John C. Marshall,
Srinivas Murthy,
Manu ShankarHari,
Jonathan A C Sterne,
Jayne F. Tierney,
Claire L. Vale
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0270668
Subject(s) - tocilizumab , medicine , placebo , meta analysis , concomitant , covid-19 , randomized controlled trial , emergency medicine , rheumatoid arthritis , alternative medicine , disease , infectious disease (medical specialty) , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom